maprotiline has been researched along with Melanoma in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to investigate the antitumour efficacy of maprotiline in mice with melanoma." | 8.84 | Maprotiline Prompts an Antitumour Effect by Inhibiting PD-L1 Expression in Mice with Melanoma. ( Chen, H; Guo, J; Jia, H; Jiang, H; Jiao, Y; Li, Y; Liang, L; Shao, M; Wu, Z; Zhang, C; Zhao, T, 2024) |
| "This study aimed to investigate the antitumour efficacy of maprotiline in mice with melanoma." | 4.84 | Maprotiline Prompts an Antitumour Effect by Inhibiting PD-L1 Expression in Mice with Melanoma. ( Chen, H; Guo, J; Jia, H; Jiang, H; Jiao, Y; Li, Y; Liang, L; Shao, M; Wu, Z; Zhang, C; Zhao, T, 2024) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, L | 1 |
| Li, Y | 1 |
| Jiao, Y | 1 |
| Zhang, C | 1 |
| Shao, M | 1 |
| Jiang, H | 1 |
| Wu, Z | 1 |
| Chen, H | 1 |
| Guo, J | 1 |
| Jia, H | 1 |
| Zhao, T | 1 |
1 other study available for maprotiline and Melanoma
| Article | Year |
|---|---|
Maprotiline Prompts an Antitumour Effect by Inhibiting PD-L1 Expression in Mice with Melanoma.
Topics: Animals; B7-H1 Antigen; Female; Maprotiline; Melanoma; Mice; Mice, Inbred C57BL; Programmed Cell Dea | 2024 |